Two forms of radiosurgery for brain metastases are equally effective
News Feb 24, 2016
While two advanced radiosurgery approaches—Gamma Knife and RapidArc®—offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center.
Their study, published in Frontiers in Oncology, compared the two different devices in brain radiosurgery. Six patients, each with three or four brain metastases, were studied.
The Gamma Knife was slightly more effective than RapidArc at focusing the beam of radiation, thus limiting spread to normal tissue, and RapidArc offered much quicker treatment compared to the Gamma Knife, researchers say. Gamma Knife treatment usually take 60-100 minutes, about 3-5 times longer than RapidArc, they say.
"In the end, using one or the other doesn't make a significant clinical difference and that is important to know because physicians and patients now know they have a choice of treatments," says the study's senior author, associate professor Wenyin Shi, MD, PhD, co-director of the Jefferson Brain Tumor Program.
Thomas Jefferson University was one of the first institutions in the US to treat patients with RapidArc technology. Its physicians have been using Gamma Knife technology for 21 years.
Understanding the benefits of advanced radiosurgery technology is essential because there has been, and will continue to be, an increase in cases of brain metastases—tumors that spread to the brain from cancer somewhere else in the body, says co-author Adam Dicker, MD, PhD, Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics at the Sidney Kimmel Medical College at Thomas Jefferson University.
"As drug therapy for cancer becomes better at controlling systemic cancer, disease in the brain increases over time. The brain is a sanctuary for cancer -- chemotherapies and targeted agents can't reach the brain and the central nervous system because of the blood-brain barrier," Dr. Dicker says. "The results are that a number of different cancers are now showing up in the brain."
Radiosurgery delivers a focused dose of radiation on tumors in order to shrink or kill the cancer, while sparing normal brain tissue. The Gamma Knife, invented in Sweden, features a circular array of 201 beams of gamma radiation that meet at a single point. The downside of the treatment, which is very accurate, is that patients wear a helmet that is fixed to the skull, Dr. Shi says. The procedure can also take a long time, he says.
RapidArc radiation is a type of linear accelerator that emits high-energy X-rays (also known as photons). Very small beams with varying intensities are aimed at a tumor and then rotated around the patient. This results in attacking the target in a complete three-dimensional manner. A single treatment can take as little as 10-15 minutes.
"We can do a comparison study like this because our Brain Tumor Program is a long-standing extremely collaborative group of specialists," Dr. Dicker says.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Liu H et al. Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife. Frontiers in Oncology, Published February 11 2016. doi: 10.3389/fonc.2016.00026
Inter-areal Balanced Amplification Enhances Signal Propagation in the BrainNews
Neuroscientists find that signal transmission in a large-scale model of the primate brain is robust under the condition in which area-to-area connections exhibit a “balance” between excitation and inhibition.READ MORE
Early Life Experiences Alter DNA Structure in the Adult BrainNews
Scientists report in the journal Science that the type of mothering a female mouse provides her pups actually changes their DNA.READ MORE
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Comments | 0 ADD COMMENT
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Sep 26 - Sep 27, 2018